Research conducted at the University of Colorado at Colorado Springs proves not everything goes downhill when it comes to aging. Older adults exhibit a better balance than younger adults in the way they process emotional information from the environment.
At age 32, Maggie Fermental suffered a stroke that left her right side paralyzed. After a year and a half of conventional therapy with minimal results, she tried a new kind of robotic therapy developed by MIT engineers. A study to appear in the April 2007 issue of the American Journal of Physical Medicine & Rehabilitation shows that the device, which helped Fermental, also had positive results for five other severe stroke patients in a pilot clinical trial.
Many young and middle-aged people of Chinese ancestry told they are at risk of going blind from glaucoma may be getting incorrect information, say researchers at the Stanford University School of Medicine.
Individuals with damage to a part of the frontal lobe make ruthless decisions when confronted with moral dilemmas that cause others to waver.
Survivors of acute lymphoblastic leukemia have a significantly increased risk of secondary cancers developing over 30 years after leukemia treatment when compared to the general population, according to a study in the March 21 issue of JAMA.
Psychiatric researchers at The Zucker Hillside Hospital campus of The Feinstein Institute for Medical Research have uncovered evidence of a new gene that appears to increase the risk of developing schizophrenia, a disorder characterized by distorted thinking, hallucinations and a reduced ability to feel normal emotions.
To establish circadian cell cycle rhythms, cell-autonomous clock mechanisms act in concert with a systemic signaling environment of which glucocorticoids are an essential part.
Disrupt the gene that regulates the biological clocks in mice and they become manic, exhibiting behaviors similar to humans with bipolar disorder, UT Southwestern Medical Center researchers have found.
A new photographic exhibit, called ?The Image of MS? has been unveiled at the Ara Pacis Museum in Rome to dispel myths about multiple sclerosis (MS), challenge public perceptions about the disease, and encourage those with symptoms to seek treatment as early as possible.
The U.S. Food and Drug Administration (FDA) approved Soliris (eculizumab), the first product for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare type of blood disorder that can lead to disability and premature death. Soliris is classified as an Orphan Drug and is a new molecular entity containing an ingredient not previously marketed in the United States.